Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$9.31 -0.08 (-0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Arcturus Therapeutics Holdings (ARCT) EV to EBITDA (2022 - 2023)

Updated

Arcturus Therapeutics Holdings' EV to EBITDA came in at 5.78 for Q3 2023, down 39.0% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) EV to EBITDA (2022 - 2023) Analysis & Trends

Over the trailing twelve months to Sep 30, 2023, Arcturus Therapeutics Holdings reported EV to EBITDA of -10.48; for FY2022, it was 4.27.

  • The five-year range for quarterly EV to EBITDA is 3.89 (Q1 2023) to 9.48 (Q2 2023).
  • Business Quant data shows ARCT's EV to EBITDA at 9.48 (Q2 2023), 3.89 (Q1 2023) and 4.26 (Q4 2022) in the three quarters before Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Arcturus Therapeutics Holdings 267.25 Mn -551.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 5.78
Jun 30, 2023 9.48
Mar 31, 2023 3.89
Dec 31, 2022 4.26
API Access

Arcturus Therapeutics Holdings EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ARCT&period=max&api_key=YOUR_API_KEY